BIOTECH ACQUISITION COMPANY - CL A SHS (BIOT)

CUSIP: G1125A108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / CL A SHS
Total 13F shares
21,483,819
Share change
+5,469,182
Total reported value
$211,397,170
Price per share
$9.84
Number of holders
76
Value change
+$53,910,825
Number of buys
33
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP G1125A108?
CUSIP G1125A108 identifies BIOT - BIOTECH ACQUISITION COMPANY - CL A SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - CL A SHS (BIOT) as of Q4 2021

As of 31 Dec 2021, BIOTECH ACQUISITION COMPANY - CL A SHS (BIOT) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,483,819 shares. The largest 10 holders included ARISTEIA CAPITAL LLC, D. E. Shaw & Co., Inc., Corbin Capital Partners, L.P., MARSHALL WACE, LLP, Saba Capital Management, L.P., CITADEL ADVISORS LLC, RiverPark Advisors, LLC, Cohanzick Management, LLC, Periscope Capital Inc., and Linden Advisors LP. This page lists 76 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.